These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

766 related items for PubMed ID: 18405445

  • 1. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD, Thomas J, Lucas SM, Bensalah K, Lotan Y, Trimmer C, Cadeddu JA.
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [Abstract] [Full Text] [Related]

  • 2. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
    Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA.
    BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
    [Abstract] [Full Text] [Related]

  • 3. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE, Farrell MA, Callstrom MR, Atwell TD, Charboneau JW, Chow GK, Dimarco DS, Patterson DE.
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [Abstract] [Full Text] [Related]

  • 4. Is radiofrequency ablation safe for solitary kidneys?
    Jacobsohn KM, Ahrar K, Wood CG, Matin SF.
    Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
    [Abstract] [Full Text] [Related]

  • 5. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
    Stern JM, Gupta A, Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, Cadeddu JA.
    BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
    [Abstract] [Full Text] [Related]

  • 6. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA.
    Cancer; 2010 Jul 01; 116(13):3135-42. PubMed ID: 20564644
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S, Kokkinaki A, Pomoni M, Galani P, Ntai S, Thanos L.
    Eur J Radiol; 2009 Feb 01; 69(2):351-6. PubMed ID: 18313248
    [Abstract] [Full Text] [Related]

  • 8. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A.
    J Urol; 2009 May 01; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [Abstract] [Full Text] [Related]

  • 9. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA.
    BJU Int; 2007 Aug 01; 100(2):287-90. PubMed ID: 17617136
    [Abstract] [Full Text] [Related]

  • 10. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.
    Eur Urol; 2012 Jun 01; 61(6):1156-61. PubMed ID: 22257424
    [Abstract] [Full Text] [Related]

  • 11. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
    Matsumoto ED, Johnson DB, Ogan K, Trimmer C, Sagalowsky A, Margulis V, Cadeddu JA.
    Urology; 2005 May 01; 65(5):877-81. PubMed ID: 15882715
    [Abstract] [Full Text] [Related]

  • 12. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.
    Eur Urol; 2013 Mar 01; 63(3):486-92. PubMed ID: 22959191
    [Abstract] [Full Text] [Related]

  • 13. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O, Badet L, Murat FJ, Maréchal JM, Colombel M, Martin X, Lyonnet D, Gelet A.
    Cardiovasc Intervent Radiol; 2008 Mar 01; 31(3):595-603. PubMed ID: 18247086
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G, Laganà D, Ianniello A, Mangini M, Fontana F, Cotta E, Concollato L, Marconi A, Recaldini C, Dionigi G, Rovera F, Boni L, Cuffari S, Fugazzola C.
    Int J Surg; 2008 Mar 01; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous radiofrequency ablation of renal tumors in solitary kidney patients.
    Jiménez E, Zurera L, Espejo JJ, Requena MJ, Campos P, Rodríguez de Tembleque L, Canis M.
    Arch Esp Urol; 2011 Mar 01; 64(1):51-8. PubMed ID: 21289386
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K, Yamakado K, Kinbara H, Nakatsuka A, Takeda K, Sugimura Y.
    Int J Urol; 2007 Jul 01; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [Abstract] [Full Text] [Related]

  • 17. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N, Hakenberg OW, Novotny V, Manseck A, Oehlschläger S, Wirth MP.
    Scand J Urol Nephrol; 2007 Jul 01; 41(1):10-3. PubMed ID: 17366096
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B, Werk M, Lopez-Hänninen E, Felix R, Althaus P.
    Cardiovasc Intervent Radiol; 2007 Jul 01; 30(4):644-9. PubMed ID: 17436034
    [Abstract] [Full Text] [Related]

  • 19. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
    Park S, Strup SE, Saboorian H, Cadeddu JA.
    Urology; 2006 Nov 01; 68(5):964-7. PubMed ID: 17113888
    [Abstract] [Full Text] [Related]

  • 20. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW, Su LM, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR, Solomon SB.
    J Urol; 2008 Aug 01; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.